Collegium Pharmaceutical, Inc. (COLL)
27.35
+0.24
(+0.89%)
USD |
NASDAQ |
Aug 24, 16:00
27.39
+0.04
(+0.14%)
After-Hours: 20:00
Collegium Pharmaceutical Max Drawdown (5Y) : 51.32% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 51.32% |
| June 30, 2026 | 51.32% |
| May 31, 2026 | 51.32% |
| April 30, 2026 | 51.32% |
| March 31, 2026 | 51.32% |
| February 28, 2026 | 51.32% |
| January 31, 2026 | 51.32% |
| December 31, 2025 | 51.32% |
| November 30, 2025 | 51.32% |
| October 31, 2025 | 51.32% |
| September 30, 2025 | 51.32% |
| August 31, 2025 | 51.32% |
| July 31, 2025 | 51.32% |
| June 30, 2025 | 51.32% |
| May 31, 2025 | 51.32% |
| April 30, 2025 | 51.32% |
| March 31, 2025 | 51.32% |
| February 28, 2025 | 52.45% |
| January 31, 2025 | 52.45% |
| December 31, 2024 | 52.45% |
| November 30, 2024 | 52.45% |
| October 31, 2024 | 54.13% |
| September 30, 2024 | 61.97% |
| August 31, 2024 | 63.88% |
| July 31, 2024 | 64.05% |
| Date | Value |
|---|---|
| June 30, 2024 | 65.22% |
| May 31, 2024 | 65.22% |
| April 30, 2024 | 65.22% |
| March 31, 2024 | 65.22% |
| February 29, 2024 | 65.22% |
| January 31, 2024 | 65.22% |
| December 31, 2023 | 65.22% |
| November 30, 2023 | 65.22% |
| October 31, 2023 | 65.22% |
| September 30, 2023 | 65.22% |
| August 31, 2023 | 65.22% |
| July 31, 2023 | 65.22% |
| June 30, 2023 | 65.22% |
| May 31, 2023 | 65.22% |
| April 30, 2023 | 65.22% |
| March 31, 2023 | 65.22% |
| February 28, 2023 | 65.22% |
| January 31, 2023 | 65.22% |
| December 31, 2022 | 65.22% |
| November 30, 2022 | 65.22% |
| October 31, 2022 | 67.64% |
| September 30, 2022 | 67.64% |
| August 31, 2022 | 67.64% |
| July 31, 2022 | 68.16% |
| June 30, 2022 | 68.16% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Innoviva, Inc. | 47.01% |
| Zevra Therapeutics, Inc. | 96.86% |
| Supernus Pharmaceuticals, Inc. | 60.67% |
| Indivior Pharmaceuticals, Inc. | 96.00% |
| Crinetics Pharmaceuticals, Inc. | 58.40% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -3.111 |
| Beta (5Y) | 0.7332 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 39.63% |
| Historical Sharpe Ratio (5Y) | 0.0918 |
| Historical Sortino (5Y) | 0.1746 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.04% |